ClinicalTrials.govpublic full text
Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma
high-risk de novo multiple myeloma, teclistamab, talquetamab, daratumumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800493
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.